Literature DB >> 16645993

Nuclear Ptdlns(3,4,5)P3 signaling: an ongoing story.

Paul Déléris1, Stéphanie Gayral, Monique Breton-Douillon.   

Abstract

Phosphatidylinositol 3,4,5-trisphosphate (Ptdlns(3,4,5)P(3)) is linked to a variety of cellular functions, such as growth, cell survival, and differentiation. Ptdlns(3,4,5)P(3) is primarily synthesized by class I phosphoinositide 3-kinases and its hydrolysis by two 3-phosphoinositide 3-phosphatases, PTEN and SHIP proteins, leads to the production of two other second messengers, Ptdlns(4,5)P(2) and Ptdlns(3,4)P(2), respectively. Evidence accumulated over the last years strongly suggest that Ptdlns(3,4,5)P(3) is an important component of signaling pathway operating within the nucleus. Moreover, recent advances indicated that nuclear translocation of cell surface receptors could activate nuclear phosphoinositide 3-kinase suggesting a new mode of signal transduction. The aim of this review is intended to summarize the state of our knowledge on nuclear Ptdlns(3,4,5)P(3) and its metabolizing enzymes, and to highlight the emerging roles for intranuclear Ptdlns(3,4,5)P(3). (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645993     DOI: 10.1002/jcb.20695

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.

Authors:  Anabel Gil; Amparo Andrés-Pons; Elena Fernández; Miguel Valiente; Josema Torres; Javier Cervera; Rafael Pulido
Journal:  Mol Biol Cell       Date:  2006-06-28       Impact factor: 4.138

2.  The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation.

Authors:  Sang Won Park; Yingjiang Zhou; Justin Lee; Allen Lu; Cheng Sun; Jason Chung; Kohjiro Ueki; Umut Ozcan
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

3.  Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.

Authors:  Oras Mistafa; Aram Ghalali; Sandeep Kadekar; Johan Högberg; Ulla Stenius
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

4.  Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.

Authors:  TanYa M Gwathmey; Karl D Pendergrass; Sean D Reid; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

5.  The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus.

Authors:  Karl D Pendergrass; Tanya M Gwathmey; Ryan D Michalek; Jason M Grayson; Mark C Chappell
Journal:  Biochem Biophys Res Commun       Date:  2009-05-03       Impact factor: 3.575

6.  Autism, asthma, inflammation, and the hygiene hypothesis.

Authors:  Kevin G Becker
Journal:  Med Hypotheses       Date:  2007-04-06       Impact factor: 1.538

Review 7.  PTEN Nuclear Functions.

Authors:  Jason Ho; Edward S Cruise; Ryan J O Dowling; Vuk Stambolic
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

8.  Different conformations of phosphatase and tensin homolog, deleted on chromosome 10 (PTEN) protein within the nucleus and cytoplasm of neurons.

Authors:  Vera L Moncalero; Roxana V Costanzo; Claudia Perandones; Martin Radrizzani
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 9.  The Role of PTEN in Epithelial-Mesenchymal Transition.

Authors:  Olga Fedorova; Sergey Parfenyev; Alexandra Daks; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

10.  Expression of yeast lipid phosphatase Sac1p is regulated by phosphatidylinositol-4-phosphate.

Authors:  Andreas Knödler; Gerlinde Konrad; Peter Mayinger
Journal:  BMC Mol Biol       Date:  2008-01-28       Impact factor: 2.946

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.